DPR was awarded this 208,000-sq.-ft. ground up solid dose pharmaceutical manufacturing facility located in Research Triangle Park, NC. With its unique architectural design, this building is one of the most recognizable in Research Triangle Park (RTP). The facility is used to produce a solid dose version of Remodulin which is a drug used to treat cardio pulmonary hypertension.
In addition to the cGMP solid dose production areas, this unique facility includes research and development labs, a 360 degree auditorium, a football shaped, glass curtainwall lobby, with an 8-foot diameter, 26-foot high aquarium and coral reef, a cafeteria, administrative offices, three mechanical penthouses, two of them with solar power panels, packaging areas and a warehouse.
The project began in April 2007 with the clearing of 35-acres of wooded area. Now completed, the project was completed on time, under budget and most importantly logged more than 650,000 safe work hours with no lost time incident. The facility is used to produce a solid dose version of Remodulin which is a drug used to treat cardio pulmonary hypertension.